Alment praktiserende læge Karen Holbøll ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  2.4% 2.5% 2.7% 2.6% 2.8%  
Credit score (0-100)  64 61 59 61 58  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  1,705 1,478 1,564 1,523 1,535  
EBITDA  536 464 502 430 413  
EBIT  304 255 353 328 325  
Pre-tax profit (PTP)  267.5 237.1 349.5 330.5 339.3  
Net earnings  206.5 181.9 266.9 255.2 262.7  
Pre-tax profit without non-rec. items  267 237 350 331 339  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  150 105 60.5 39.0 13.8  
Shareholders equity total  616 798 1,065 920 932  
Interest-bearing liabilities  480 451 0.0 0.0 0.0  
Balance sheet total (assets)  1,417 1,451 1,279 1,154 1,184  

Net Debt  -352 -584 -880 -674 -972  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,705 1,478 1,564 1,523 1,535  
Gross profit growth  17.4% -13.3% 5.8% -2.6% 0.8%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,417 1,451 1,279 1,154 1,184  
Balance sheet change%  -24.8% 2.4% -11.9% -9.7% 2.6%  
Added value  536.0 463.7 502.2 477.5 412.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -465 -418 -276 -124 -113  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  17.8% 17.2% 22.5% 21.5% 21.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.4% 17.8% 25.9% 27.2% 29.0%  
ROI %  22.0% 21.7% 30.6% 33.3% 36.6%  
ROE %  40.3% 25.7% 28.7% 25.7% 28.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  43.5% 55.0% 83.3% 79.7% 78.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -65.7% -126.0% -175.3% -156.6% -235.6%  
Gearing %  77.9% 56.5% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.2% 3.8% 2.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.2 1.9 8.6 5.9 6.7  
Current Ratio  1.2 1.9 8.6 5.9 6.7  
Cash and cash equivalent  831.8 1,034.8 880.3 673.8 972.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  196.7 587.8 1,056.6 908.8 975.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  536 464 502 477 413  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  536 464 502 430 413  
EBIT / employee  304 255 353 328 325  
Net earnings / employee  206 182 267 255 263